Truist Financial Lowers The Pennant Group (NASDAQ:PNTG) Price Target to $28.00

The Pennant Group (NASDAQ:PNTG - Get Free Report) had its target price dropped by equities researchers at Truist Financial from $32.00 to $28.00 in a research report issued on Friday,Benzinga reports. The firm currently has a "hold" rating on the stock. Truist Financial's target price suggests a potential upside of 26.07% from the stock's current price.

PNTG has been the subject of a number of other research reports. Wells Fargo & Company initiated coverage on The Pennant Group in a research note on Thursday, December 19th. They set an "equal weight" rating and a $33.00 price objective for the company. Oppenheimer increased their price target on shares of The Pennant Group from $34.00 to $37.00 and gave the company an "outperform" rating in a research report on Friday, November 8th. Two analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $35.20.

The Pennant Group Trading Down 3.9 %

Shares of PNTG traded down $0.89 during trading hours on Friday, hitting $22.21. The company had a trading volume of 363,153 shares, compared to its average volume of 210,497. The Pennant Group has a 52-week low of $18.21 and a 52-week high of $37.13. The company has a quick ratio of 1.12, a current ratio of 1.12 and a debt-to-equity ratio of 0.58. The stock's 50 day moving average price is $26.18 and its 200 day moving average price is $30.24. The firm has a market cap of $764.69 million, a P/E ratio of 32.66, a P/E/G ratio of 2.24 and a beta of 2.06.

Remove Ads

Institutional Trading of The Pennant Group

A number of institutional investors and hedge funds have recently added to or reduced their stakes in PNTG. Franklin Resources Inc. raised its holdings in The Pennant Group by 26.6% in the 3rd quarter. Franklin Resources Inc. now owns 18,347 shares of the company's stock worth $638,000 after purchasing an additional 3,859 shares in the last quarter. JPMorgan Chase & Co. increased its position in shares of The Pennant Group by 68.4% during the third quarter. JPMorgan Chase & Co. now owns 205,922 shares of the company's stock valued at $7,351,000 after buying an additional 83,664 shares during the period. FMR LLC raised its stake in The Pennant Group by 51.3% in the third quarter. FMR LLC now owns 2,528,512 shares of the company's stock worth $90,268,000 after buying an additional 856,838 shares in the last quarter. Barclays PLC lifted its holdings in The Pennant Group by 375.0% in the third quarter. Barclays PLC now owns 49,101 shares of the company's stock worth $1,753,000 after buying an additional 38,763 shares during the period. Finally, Point72 Asset Management L.P. bought a new stake in The Pennant Group during the 3rd quarter valued at approximately $685,000. Hedge funds and other institutional investors own 85.88% of the company's stock.

The Pennant Group Company Profile

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.